[1] Mazzaferri EL,Kloos RT. Clinical review 128:Current approaches to primary therapy for papillary and follicular thyroid cancer[J]. J Clin Endocrinol Metab,2001,86(4):1447-1463.
[2] Zimmerman D,Hay ID,Gough IR,et al. Papillary thyroid carcinoma in children and adults:long-term follow-up of 1039 patients conservatively treated at one institution during three decades[J]. Surgery,1988,104(6):1157-1166.
[3] Farahati J,Bucsky P,Parlowsky T,et al. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age,gender,and history[J]. Cancer,1997,80(11):2156-2162.
[4] Ringel MD,Anderson J,Souza SL,et al. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer[J]. Mod Pathol,2001,14(4):289-296.
[5] Patel A,Jhang S,Dogra S,et al. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents[J]. Pediatr Res,2002,52(5):737-744.
[6] Khan MU,Nawaz MK,Saadullah M,et al. Differentiated thyroid carcinoma in a juvenile patient[J]. Clin Nucl Med,2008,33(5):319-320.
[7] Parisi MT,Mankoff D,Differentiated pediatric thyroid cancer,correlates with adult disease,controversies in treatment[J]. Semin Nucl Med,2008,37(5):340-356.
[8] Sisson JC,Giordano TJ,Jamadar DA,et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma[J]. Cancer,1996,78(10):2184-2192.
[9] Hung W,Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid Cancer:a review[J]. Thyroid,2002,12(8):683-702.
[10] Dottorini ME,Vignati A,Mazzucchelli L,et al. Differentiated thyroid carcinoma in children and adolescents:a 37-year experience in 85 patients[J]. J Nucl Med,1997,38(5):669-675.
[11] Samuel AM,Rajashekharrao B,Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer[J]. J Nucl Med,1998,39(9):1531-1536.
[12] Junak DH,Wloch J,Roskosz J,et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregion-al recurrence risk in childhood and adolescent differentiated thyroid cancer[J]. J Nucl Med,2007,48(6):879-888.
[13] Bal CS,Kumar A,Pant GS. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma:a randomized clinical trial in 509 patients[J]. J Clin Endocrinol Metab,2004,89(4):1666-1673.
[14] Dinauera CA,Breuerb C,Rivkees SA. Differentiated thyroid cancer in children; diagnosis and management[J].Curr Opin Oncol,2008,20(1):59-65.